QGEN · Categories · M&A
QGEN - Mergers and acquisitions
Qiagen N.V. (QGEN) mergers and acquisitions - real-time wire coverage filtered to M&A only.
Recent M&A for QGEN
- QIAGEN Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics With NGS TechnologiesVerogen a proven leader in equipping forensic science laboratories and criminal investigators to use next-generation sequencing (NGS) to gain deeper insights Addition of Verogen strengthens QIAGEN leadership in fast-growing field of Human ID / forensics anchored by sample collection and preparation, genetic testing analysis and workflow automation Deal builds on partnership launched in 2021 to distribute Verogen's Illumina MiSeq FGx sequencer, NGS-based panels and GEDmatch bioinformatics solutions QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))) today announced it has completed the acquisition of Verogen, a leader in the use of next-generation sequencing (NGS) technologies to driv
- QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.BLIRT adds new R&D and manufacturing capabilities for customized and standardized recombinant enzymes, as well as molecular biology reagents Strengthens QIAGEN's sample technologies business, one of the company's five pillars of growth, also with additional global production capacities and broader commercial reach 96% majority stake acquired in BLIRT SA through the transaction with a group of leading shareholders QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA))) announced today that it has signed agreements to acquire a 96% majority ownership stake in BLIRT SA (Polish Stock Exchange: BLR), a manufacturer of recombinant enzymes for the life science industry based in Gdansk, Pol